Moderna Stock News

The FDA has authorized Moderna Inc (NASDAQ: MRNA ) and Pfizer Inc (NYSE: PFE ) / BioNTech SE''s (NASDAQ: BNTX ) COVID-19 booster shots for all U.S. adults. The agency extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. The booster dose from Pfizer is the same dosage strength as Full story available on Benzinga.com

The head of South Koreas national health protection agency was vaccinated with a third dose of Modernas COVID-19 vaccine on Friday, having received two AstraZeneca doses more than six months ago. Jeong Eun-kyeong, the Korea Disease Co

The United States Food and Drug Administration (FDA) is expected to approve booster shots of Pfizer-BioNTech and Moderna''s coronavirus vaccines at once, Politico reported citing two people with kn

Harbor Investment Advisory LLC cut its stake in Moderna, Inc. (NASDAQ:MRNA) by 4.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,024 shares of the company’s stock after selling 639 shares during the period. Moderna makes up about 0.7% of Harbor Investment […]

The National Immunisation Advisory Committee (NIAC) has recommended that People who received the Johnson and Johnson Covid-19 vaccine should receive a booster vaccine three months after vaccination. Boosters for anyone who received the Pfizer, Moderna or AstraZeneca vaccine are to be delivered following a minimum interval of five months. A total of 236,313 people received []

California''s online vaccine scheduler now reflects changes in its booster policy announced last week regarding eligibility for Pfizer and Moderna recipients.

By Woo Jae-yeon SEOUL, Nov. 18 (Yonhap) -- Samsung Group''s de facto leader Lee Jae-yong has met with leaders of Moderna and Verizon in the United States to enhance cooperation with the global partners, Samsung said Thursday, as part of efforts to secur

California''s online vaccine scheduler now reflects changes in its booster policy announced last week regarding eligibility for Pfizer and Moderna recipients.

Wedbush Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA) by 7.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,842 shares of the companys stock after acquiring an additional 422 shares during the quarter. Wedbush Securities Inc.s holdings in Moderna were []

The German vaccination committee STIKO advises all vaccinated adults to give an extra shot with the corona vaccines from Pfizer/BioNTech or Moderna. The so-called booster shot is currently only available for the oldest residents of Germany and other risk groups. According to the committee, the booster should ensure that vaccinated persons remain well protected […] The post German Vaccination Commission Recommends Boosters for People Over 18 appeared first on Dawn News .

Moderna asked the U.S. Food and Drug Administration on Wednesday to allow emergency use of the company''s coronavirus vaccine booster for all adults aged 18 and older.

Seoul, Nov 18 (IANS) Samsung Groups de facto leader Lee Jae-yong has met with leaders of biotech company Moderna and telecom career Verizon in the US to enhance cooperation with the global partners, the company said on Thursday, as part of efforts to secure the conglomerates next growth engines. Lee, vice chairman of Samsung Electronics, [] The post Samsung chief discusses Covid vaccine development with Moderna appeared first on Buziness Bytes .

Moderna (MRNA) stock rallied just over 3% on Wednesday in a continuation of recent small gains seen after the tumultuous hammering the stock has suffe

New figures reveal that the top three Covid vaccine makers Pfizer, BioNTech, and Moderna are making around $65,000, in combined profit per minute, from their jabs. According to new analysis, the big pharma giants are [] The post Big Pharma Vaccine Makers Making $1,000 In Profit Every Second From Covid Jabs appeared first on News Punch .

Moderna has refiled its application to administer booster shots of its COVID-19 vaccine to the US Food and Drug Administration.